Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (2S) 2 benzyl 3 (cis hexahydro 2 isoindolinylcarbonyl)propionic acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101346352B reveals efficient Rh-catalyzed asymmetric reduction for Mitiglinide. Offers high optical purity and industrial scalability for diabetes drug intermediates.
Patent CN101346352B reveals a novel rhodium-catalyzed asymmetric reduction for Mitiglinide intermediates, offering superior optical purity and industrial scalability for pharmaceutical manufacturers.